Back to Results

Baird Medical Investment Holdings Ltd (BDMD)

Baird Medical Investment Holdings Ltd. is a common stock listing of a healthcare company focused on medical devices. Through its subsidiaries, the company develops, manufactures, and sells microwave ablation systems and related devices in the People’s Republic of China. Its product range includes microwave ablation apparatus and needles, long microwave ablation needles, and fine microwave ablation needles used in the treatment of benign and malignant tumors such as thyroid nodules, liver cancer, lung cancer, and breast lumps, as well as for soft tissue ablation. The company distributes its products through third-party distributors. Baird Medical Investment Holdings Ltd. was founded in 2012 and is headquartered in Guangzhou, China.


Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Market Outlook FAQ

Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Dividend Yield Next Earnings Date Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score
NASDAQ-BDMD
$1.23
17.4% Upside
Fair
$4
281.0% Upside
Bargain
Weak
0.0%
December 4, 2026
1.3x
1.8x
44.319 M
62.427 M
29.8%
39.3%
4.0
Valuation • Fair Value

Baird Medical Investment Holdings Ltd (NASDAQ-BDMD) Fair Value by Valuation Model

Review the available estimates for Baird Medical Investment Holdings Ltd (NASDAQ-BDMD), including DCF Fair Value, EPV Fair Value, Comps Fair Value.

Primary Valuation Read

Fair Value

$1.23

Estimated upside of 17.4% versus the current market price.

Fair Value Confidence

Low

Confidence level for the primary fair value estimate.

DCF Fair Value

$1.17

Discounted cash flow valuation reference.

EPV Fair Value

$1.90

Earnings power value estimate.

Comps Fair Value

$1.19

Comparable-company valuation reference.

Analyst Price Target

$4

Analysts imply upside of 281.0%.

How to read these valuation models

Use the 6 available valuation references for Baird Medical Investment Holdings Ltd (NASDAQ-BDMD) as analytical inputs, not a standalone conclusion. Valuation methods can differ because they rely on different assumptions, time horizons and financial inputs; compare the estimates with the current price and the company’s financial quality.

Profitability • Growth

Profitability & Growth for Baird Medical Investment Holdings Ltd (NASDAQ-BDMD)

Review the profitability and growth indicators currently supported by the latest data.

Revenue

24.493 M

Current operating scale indicator.

Revenue Forecast

27.516 M

Forward revenue estimate.

EBITDA

-13.275 M

Current operating profitability reference.

EBITDA Forecast

6.809 M

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review Baird Medical Investment Holdings Ltd (NASDAQ-BDMD) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Baird Medical Investment Holdings Ltd (NASDAQ-BDMD)

Review the financial quality and risk indicators currently supported by the latest data.

Financial Health

Weak

Financial pressure deserves closer review.

Piotroski Score

3

Weak quality score that deserves closer review.

Beneish M-Score

-3.00

No elevated caution signal from this screen.

Altman Z-Score

4.0

Relatively strong balance-sheet zone.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Baird Medical Investment Holdings Ltd (NASDAQ-BDMD). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Baird Medical Investment Holdings Ltd (NASDAQ-BDMD)

Track the upcoming dates and dividend metrics currently supported by the latest data.

Next Earnings Date

December 4, 2026

Days to Earnings

77

Dividend Yield

0.0%

No current dividend yield is indicated.

How to read events and dividends

This section helps investors track time-sensitive items for Baird Medical Investment Holdings Ltd (NASDAQ-BDMD), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Technical Outlook

Technical Signals by Time Frame

Review the technical signals currently available for this stock across supported time frames.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Sell

The 15-minute technical read for Baird Medical Investment Holdings Ltd (NASDAQ-BDMD) is currently Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Sell

The 1-hour technical read for Baird Medical Investment Holdings Ltd (NASDAQ-BDMD) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Sell

The daily technical read for Baird Medical Investment Holdings Ltd (NASDAQ-BDMD) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Sell

The weekly technical read for Baird Medical Investment Holdings Ltd (NASDAQ-BDMD) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Sell

The monthly technical read for Baird Medical Investment Holdings Ltd (NASDAQ-BDMD) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

FAQ • Fast Investor Answers

Baird Medical Investment Holdings Ltd (NASDAQ-BDMD) Stock FAQ

Data-supported answers about Baird Medical Investment Holdings Ltd (NASDAQ-BDMD), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value
$1.23
Estimated upside 17.4%
Valuation Rating
Undervalued
Estimated upside of 17.4%
Analyst Target
$4
Implied upside 281.0%
Financial Health
Weak
Current financial-health read

The current fair value estimate for Baird Medical Investment Holdings Ltd (NASDAQ-BDMD) is $1.23. This implies an estimated upside of 17.4% versus the current market price.

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 17.4% versus the current market price.

The available analyst price target for Baird Medical Investment Holdings Ltd (NASDAQ-BDMD) is $4. The analyst target implies estimated upside of 281.0%.

The current financial health read for Baird Medical Investment Holdings Ltd (NASDAQ-BDMD) is Weak. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Baird Medical Investment Holdings Ltd (NASDAQ-BDMD) is December 4, 2026.

The latest available data indicates no current dividend yield for Baird Medical Investment Holdings Ltd (NASDAQ-BDMD).

The current market capitalization listed for Baird Medical Investment Holdings Ltd is 44.319 M.

The current enterprise value listed for Baird Medical Investment Holdings Ltd is 62.427 M. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Baird Medical Investment Holdings Ltd is NASDAQ-BDMD, and the stock is listed on NASDAQ.

Baird Medical Investment Holdings Ltd (NASDAQ-BDMD) is listed on NASDAQ.

The current debt-to-total-capital ratio listed for Baird Medical Investment Holdings Ltd is 29.8%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Baird Medical Investment Holdings Ltd is 39.3%. Free float helps investors understand how much of the share base is available for public trading.

Similar Healthcare Equipment & Supplies Stocks View more on NASDAQ

Comparable companies from the same industry, limited to one security per issuer.

ABT NYSE Abbott Laboratories Fair Value Fair Market Cap 177.6 B
ISRG NASDAQ Intuitive Surgical Inc Fair Value Fair Market Cap 139 B
MDT NYSE Medtronic PLC Fair Value Fair Market Cap 117.8 B
SYK NYSE Stryker Corporation Fair Value Fair Market Cap 105.5 B
BSX NYSE Boston Scientific Corp Fair Value Undervalued Market Cap 62.81 B
EW NYSE Edwards Lifesciences Corp Fair Value Fair Market Cap 50.873 B
BDX NYSE Becton Dickinson and Co Fair Value Undervalued Market Cap 49.286 B
MDLN NASDAQ Medline Inc Fair Value Fair Market Cap 41.807 B
IDXX NASDAQ IDEXX Laboratories Inc Fair Value Fair Market Cap 40.289 B
DXCM NASDAQ DexCom Inc Fair Value Fair Market Cap 33.717 B
RMD NYSE ResMed Inc Fair Value Undervalued Market Cap 32.188 B
ALC NYSE Alcon AG Fair Value Undervalued Market Cap 31.559 B
GEHC NASDAQ GE HealthCare Technologies Inc Fair Value Undervalued Market Cap 28.967 B
PHG NYSE Koninklijke Philips NV ADR Fair Value Undervalued Market Cap 24.25 B
STE NYSE STERIS plc Fair Value Undervalued Market Cap 19.991 B
ZBH NYSE Zimmer Biomet Holdings Inc Fair Value Undervalued Market Cap 18.189 B
SOLV NYSE Solventum Corp Fair Value Fair Market Cap 15.123 B
PEN NYSE Penumbra Inc Fair Value Fair Market Cap 12.51 B
BAX NYSE Baxter International Inc Fair Value Undervalued Market Cap 11.788 B
SNN NYSE Smith & Nephew SNATS Inc Fair Value Undervalued Market Cap 11.577 B